JBCHEPHARM.NS(JBCHEPHARM.NS)
JBCHEPHARM.NS
No analyst ratings available
No analyst price targets available for JBCHEPHARM.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $47.18B | $54.25B | $57.06B |
| Low | $44.10B | $51.06B | $53.53B |
| High | $51.67B | $58.52B | $61.99B |
| EBITDA Avg | $15.61B | $17.96B | $18.89B |
| Low | $14.59B | $16.90B | $17.72B |
| High | $17.10B | $19.37B | $20.52B |
| EBIT Avg | $12.79B | $14.71B | $15.47B |
| Low | $11.96B | $13.84B | $14.51B |
| High | $14.01B | $15.87B | $16.81B |
| Net Income Avg | $9.62B | $12.09B | $13.12B |
| Low | $8.42B | $11.33B | $12.07B |
| High | $10.61B | $13.56B | $14.60B |
| EPS Avg | $60.29 | $75.74 | $82.21 |
| Low | $52.76 | $70.96 | $75.60 |
| High | $66.44 | $84.96 | $91.45 |
| Analysts (Rev / EPS) | 8 / 9 | 8 / 9 | 4 / 3 |